BioCardia BCDA
NASDAQ BCDA
$1.10 -0.01 (-0.90%)
At close: Sep 9, 2026 · 4:00 PM EDT

BioCardia (BCDA) Non-Current Assets (2010 - 2026)

BioCardia's (BCDA) quarterly Non-Current Assets came in at $457000.0 in Q2 2026, down 48.65% year-over-year from $890000.0 in Q2 2025, and down 20.1% quarter-over-quarter from $572000.0 in Q1 2026.

Analysis

BioCardia (BCDA) Non-Current Assets (2010 - 2026) Analysis & Trends

BioCardia (BCDA) has reported Non-Current Assets for 13 consecutive years, with $457000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 48.65% year-over-year to $457000.0 in Q2 2026; TTM through Jun 2026 was $2.5 million, a 40.59% decrease from a year earlier, with the FY2025 full-year figure at $681000.0, down 38.2% from the prior year.
  • Non-Current Assets was $457000.0 for Q2 2026 at BioCardia, down from $572000.0 in the prior quarter.
  • Over five years, Non-Current Assets peaked at $2.2 million in Q1 2022 and troughed at $457000.0 in Q2 2026.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2024 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets surged 525.0% in 2022 and plunged 48.65% in 2026, its largest moves.
  • Over 5 years, Non-Current Assets stood at $1.9 million in 2022, then slipped by 20.89% to $1.5 million in 2023, then dropped by 27.79% to $1.1 million in 2024, then plunged by 38.2% to $681000.0 in 2025, then tumbled by 32.89% to $457000.0 in 2026.
  • The last three Non-Current Assets figures came in at $457000.0 (Q2 2026), $572000.0 (Q1 2026), and $681000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 441.00 Mn
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - 279.00 Mn
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn 451.27 Mn
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 523.50 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn 150.83 Mn
6 Beam Therapeutics 3.06 Bn 3.06 Bn - 207.76 Mn
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 35.91 Mn
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn 964.69 Mn
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 238.14 Mn
10 BioCardia 13.06 Mn 8.94 Mn - 457,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 457,000.00
Mar 31, 2026 572,000.00
Dec 31, 2025 681,000.00
Sep 30, 2025 783,000.00
Jun 30, 2025 890,000.00
Mar 31, 2025 993,000.00
Dec 31, 2024 1.10 Mn
Sep 30, 2024 1.21 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.42 Mn
Dec 31, 2023 1.53 Mn
Sep 30, 2023 1.63 Mn
Jun 30, 2023 1.74 Mn
Mar 31, 2023 1.84 Mn
Dec 31, 2022 1.93 Mn
Sep 30, 2022 2.03 Mn
Jun 30, 2022 2.11 Mn
Mar 31, 2022 2.18 Mn
Dec 31, 2021 2.24 Mn
Sep 30, 2021 324,000.00